oseen · source-linked reporting
Cyprus approves the use of human COVID-19 medication molnupiravir to combat a local feline virus mutation
causing feline infectious peritonitis resulting in numerous cat deaths locally. The government assures that there is no risk of depleting medication stocks for potential COVID-19 surges in the human population.
Context: 2023 Carinthia and Slovenia floods.
Cyprus approves the use of human COVID-19 medication molnupiravir to combat a local feline virus mutation causing feline infectious peritonitis resulting in numerous cat deaths locally. The government assures that there is no risk of depleting medication stocks for potential COVID-19 surges in the human population.
Event summary via Wikipedia Current Events (2023-08-04).